Drug Companies Disenchanted; Device Companies Depart
The question is, are both Bristol-Myers Squibb and Pfizer preparing to sell their orthopedics businesses and get out of medical devices altogether? And where would buyers for both be found?
You may also be interested in...
Amid a case of re-infection of a vaccinated healthcare worker in western China’s Xi’an city, and ongoing debate over domestic vaccines' efficacy, increasing attention is being paid in China to raising inoculation rates for COVID-19 and moving towards herd immunity.
The company announced new research investments and partnerships with the American Diabetes Association and the T1D Exchange to address racial disparities in treatment of diabetes.
Two top officials in the US FDA’s device center are warning of delays in the agency’s review of submissions for new products that aren’t directly tied to the coronavirus pandemic.